Clinical Trial VICCBRE1271
Title
Observational Pilot Study on MRI and Blood-Based Biomarkers of Chemotherapy-Related Cognitive Impairment
Principal Investigator(s)
Tricia Thornton-Wells
Details
- Protocol No. VICCBRE1271
- Open Date: 01/09/2013
- Staging: Pilot
- Age Group: Adults
- Scope: Local
- Objective: Aim 1 - Evaluate the Relationship between Cognitive Impairment and MRI and Blood-Based Biomarkers Aim 2 - Identify Genetic Risk Factors for Chemotherapy-Induced Cognitive Impairment (CICI). Aim 3 - Develop and Compare Predictive Models for CICI using Genetic and MRI Biomarkers.
- Disease Sites: Breast
- Therapies: None Specified
- Drugs: None Specified
- Participating Institutions: Vanderbilt University
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
